Table 2.
Delivery characteristics and maternal and fetal/neonatal adverse events.
| Characteristic | Preterm PE n = 34 | Control n = 64 | p-value | Term PE n = 25 | Control n = 45 | p-value |
|---|---|---|---|---|---|---|
| GA at delivery, wk+d | 30+4 [22+0; 37+3] | 38+3 [26+3; 42+0] | < 0.001 | 39+0 [37+4; 41+4] | 39+4 [37+0; 41+4] | n.s. |
| Maternal adverse events | < 0.001 | n.s. | ||||
| - Eclampsia | 1 (2.9) | 0 | 0 | 0 | ||
| - HELLP syndrome | 2 (5.9) | 0 | 2 (8) | 0 | ||
| - Death | 0 | 0 | 0 | 0 | ||
| - Cerebral hemorrhage | 0 | 0 | 0 | 0 | ||
| - Cerebral thrombosis | 0 | 0 | 0 | 0 | ||
| - Pulmonary oedema | 1 (2.9) | 0 | 0 | 0 | ||
| - Acute renal injury | 1 (2.9) | 0 | 0 | 1 (2.2) | ||
| - DIC | 0 | 0 | 0 | 0 | ||
| Birth weight,g | 1295 [400; 2770] | 2950 [576; 4280] | < 0.001 | 3150 [2360; 4220] | 3280 [1690; 4740] | n.s. |
| Fetal/neonatal adverse events (multiple selections possible) | < 0.001** | n.s.** | ||||
| - Fetal or perinatal death | 1 (2.9) | 1 (1.6) | n.s. | 0 | 0 | |
| - Preterm birth < 34 | 15 (44.1) | 3 (4.7) | 0.05 | NA | NA | |
| WOG | ||||||
| - IUGR | 11 (32.4) | 15 (23.4) | n.s. | 4 (16) | 8 (17.8) | |
| - Placental abruption | 1 (2.9) | 1 (1.6) | n.s. | 0 | 0 | |
| - ARDS | 13 (38.2) | 6 (9.4) | 0.004 | 3 (12) | 0 | |
| - NEC | 1 (2.9) | 1 (1.6) | n.s | 0 | 0 | |
| - IVH | n.s | |||||
| IVH 1-11° | 2 (5.9) | 0 | 1 (4) | 0 | ||
| IVH 111-IV° | 0 | 1 (1.6) | 0 | 0 |
Reported are median and interquartile range or number and percentage,
**
Reported p-value over all groups.
ARDS, acute respiratory distress syndrome; DIC, disseminated intravascular coagulation; HELLP, haemolysis, elevated liver enzymes, low platelets; IUGR, intrauterine growth restriction; IVH, intraventricular hemorrhage; NEC, necrotising enterocolitis; PE, preeclampsia; wk+d, weeks+days; WOG, weeks of gestation.